FDA Investigator Matthew J Johnson
Matthew J Johnson has conducted inspections on 25 sites in 2 countries as of 15 Dec 2014. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
25
Last Inspection Date:
15 Dec 2014
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
China
FDA Investigators that have inspected at least one site in common with Matthew J Johnson:
Ademola O Daramola,
Alexandra B Pitkin,
Allison A Rodriguez,
Anderson,
Anissa M Vargas,
Anita Narula, PhD,
Anna L Marroquin,
Arie C Menachem,
Ashar P Parikh,
Babajide Michael Osunsanmi,
Binh T Nguyen,
Brian J Ryan,
Brian P Putz,
Bryan A Galvez,
Burnsb,
Carla J Lundi,
Caryn M Everly,
Caryn M Mcnab,
Cathleen A Carr Sharpe,
Charles L Larson,
Charles M Edwards,
Chelsea N Sealey,
Chiang Syin, PhD,
Christopher M Jenner,
Christopher R Czajka,
Claudia Mperez Kasmarski,
Crystal Monroy,
Daniel R Solis,
Darrin E Davis,
David G Whitman,
David Serrano,
Davis,
Deborah A Greco,
Deborah J Parris,
Deborah W Hsu,
Dogbeda F Mackenzie,
Dolores Harper,
Donald L Lech,
Donna Mwilliams Hill, PhD,
Dr. Robert C Horan, MD,
Eric L Dong, BS,
Erik M Slama,
Erika V Butler,
Eugene Y Chang,
Felix Maldonado,
Francisco,
Greg K Keshishyan,
Gunneet Kaur,
Jamie M Du,
Jane S Wernberg,
Janet Pulver,
Jennifer M Gogley,
Jeremy Beber,
Jeremy H Nguyen,
Jinnie Kokiatkulkij,
Jocelyn E Massey,
Jocelyn E Sparks,
Joey V Quitania,
John A Gonzalez,
John C Su,
John M Dietrick,
Jose A Lopez,
Jose R Hernandez,
Judy C Nepsa,
Julie A Rorberg,
Julie A Stocklin,
Ka L Wong,
Kari M Johansen,
Katherine E Jacobitz,
Kelley,
Kelvin Cheung,
Kelvin X Sanders,
Kevin T Gerrity,
Kham Phommachanh,
Khoa Nathanv Tran,
Kim Lthomas Cruse,
Lata C Mathew, PhD,
Laurimer Kuilan Torres,
Lewisjess,
Lilly O Barton,
Liming Zhang,
Linda Thai,
Lisa Shin,
Louis B Cencetti,
Lucas B Leake,
Marcus F Yambot,
Marie Falcone,
Marie T Falcone,
Mark A Tucker,
Mark C Saale,
Maxyne T Lam,
Michael D Garcia,
Mihaly S Ligmond,
Nancy E Byerly,
Nancy L Rolli,
Natalie J Ayoub,
Nicholas L Hunt,
Osama A Khatib,
Patricia F Alberico,
Paul A Bonneau,
Paul F Rader,
Rachel C Stanton,
Raymond T Oji,
Robert C Coleman,
Roger F Zabinski,
Saied A Asbagh,
Santiago Gallardo Johnson,
Sara Jdent Acosta,
Sarah A Hassas,
Sarah R Barker,
Shirnette D Ferguson,
Simone E Pitts,
Sonia R Peterson,
Sonya L Karsik, RAC,
Sparky L Bartee,
Stephanie A Slater, MS,
Sudipan Karmakar,
Susan W Ting,
Taichun Qin, PhD,
Tajah L Blackburn,
Tamala P Magee,
Terri L Dodds,
Thanh B Tran,
Thao T Kwan,
Theresa Kirkham (NMI),
Thomas R Beilke,
Tiara Nbrown Crosen,
Timothy T Kapsala,
Tracey T Duong,
Travell D Sawyer,
Uttaniti Limchumroon (Tom),
Vickie L Anderson,
Virgilio F Pacio, CSO,
William J Leonard,
Yen Tso Kuo,
Yumi J Hiramine,
Yvette Mlacour Davis,
Zachary A Bogorad,
Zachary L Stamm,
Zi Qiang Gu
Matthew J Johnson's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| August, 2013 | FDA 483 | Bausch & Lomb Incorporated - Form 483, 2013-08-23 |
| October, 2014 | FDA 483 | kdc/one Chatsworth, Inc - Form 483, 2014-10-17 |
| March, 2013 | EIR | Pacira Pharmaceuticals, Inc. - EIR, 2013-03-27 |
| May, 2013 | FDA 483 Response | Cardinal Health 414, LLC - Form 483R, 2013-05-01 |
| May, 2013 | FDA 483 | Cardinal Health 414, LLC - Form 483, 2013-05-01 |
| July, 2013 | FDA 483 | Levlad, LLC - Form 483, 2013-07-12 |
| November, 2014 | FDA 483 | Ethical Nutritional, LLC - Form 483, 2014-11-19 |
| May, 2013 | EIR | Cardinal Health 414, LLC - EIR, 2013-05-01 |
| July, 2013 | FDA 483 | Recsei Laboratories LLC - Form 483, 2013-07-02 |
| March, 2013 | FDA 483 | Pacira Pharmaceuticals, Inc. - Form 483, 2013-03-27 |
| December, 2014 | FDA 483 | FNC MEDICAL CORPORATION - Form 483, 2014-12-18 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more